Takashi Ebihara (Ebi), PhDCOO at GeneFrontier CorporationSpeaker
Profile
The COO of GeneFrontier Corporation since 2010, with a focus on advancing cell-free protein expression technologies, particularly the PURE system. Earned a Ph.D. in cell-free protein synthesis from Tokyo Institute of Technology in 2000, and played a key role in the establishment of GeneFrontier in 2003, leveraging his deep expertise in cell-free protein synthesis following experience in life science venture capital.
Agenda Sessions
Cell Free Antibody Engineering: Accelerating Discovery and Screening with PUREfrex®
, 12:35pmView Session
